Li Q et al. proved for the first time that genetic variations in the transforming growth factor-β (TGF-β), PI3K/protein kinase B (AKT) pathways were associated with an increased risk of brain metastasis in NSCLC patients (67, 68). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.